trifluridine

Ligand id: 8697

Name: trifluridine

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 3
Topological polar surface area 99.1
Molecular weight 296.06
XLogP -0.08
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
Approved drug? Yes (Japan only)
IUPAC Name
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione
International Nonproprietary Names
INN number INN
4146 trifluridine
Synonyms
TFT | trifluorothymidine
Database Links
ChEMBL Ligand CHEMBL1129
DrugBank Ligand DB00432
GtoPdb PubChem SID 252166897
PubChem CID 6256
Search Google for chemical match using the InChIKey VSQQQLOSPVPRAZ-RRKCRQDMSA-N
Search Google for chemicals with the same backbone VSQQQLOSPVPRAZ
Search PubMed clinical trials trifluridine
Search PubMed titles trifluridine
Search PubMed titles/abstracts trifluridine
Search UniChem for chemical match using the InChIKey VSQQQLOSPVPRAZ-RRKCRQDMSA-N
Search UniChem for chemicals with the same backbone VSQQQLOSPVPRAZ
Comments
Trifluridine was originally approved by the US FDA in 1980, and was used for its antiviral effects (marketed as Vitroptic®). The drug is now being investigated for its antineoplastic (cytotoxic) effect.